The film will go into limited release December 1.
NYS Entity Status
NYS Filing Date
MAY 07, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - BURKE DEVELOPMENT ASSOCIATES LIMITED LIABILITY COMPANY
Around the Web
- Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
By Deadline - Tuesday Jul 25, 2017
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- New Development: Soft in the Middle, Splashy Up Top
By STEFANOS CHEN - Friday Sep 15, 2017
The luxury market in New York is pulling in two directions, with developers betting on big-ticket palatial aeries and million-dollar “starter” homes.
- Knicks add Trey Burke to chaotic point-guard situation
By Marc Berman - Wednesday Oct 11, 2017
With Joakim Noah’s drug suspension for the first 12 games, the Knicks are granted an extra roster spot and likely will use it on a point guard. On Wednesday, the Knicks may have found one. They signed former Utah point guard Trey Burke to a non-guaranteed contract. He’s likely not here to solve their point-guard...
- Express Scripts to limit opioids; doctors concerned
By Jim Salter - Wednesday Aug 16, 2017
ST. LOUIS — The largest U.S. pharmacy benefit manager will soon limit opioid drugs for first-time users as part f a wide-ranging effort to curb an epidemic.[...] the new program from Express Scripts is drawing criticism from the American Medical Association, the largest association of physicians and medical students in the U.S., which believes treatment plans should be left to doctors and patients.Express Scripts started a yearlong pilot program in 2016 to reduce patients’ dependency on opioids and the risk of addiction, said Snezana Mahon, the company’s vice president of clinical product development.Mahon said analysis of 106,000 patients in the program showed a 38 percent reduction in hospitalizations and a 40 percent drop in emergency room visits, compared with a control group.The program is scheduled to take effect nationwide on Sept. 1 for Express Scripts members whose employer or health insurer has enrolled to participate.Dosage is also limited, and the company will monitor and try to prevent for patterns of potential “pill shopping,” where a patient goes from doctor to doctor to collect prescriptions.Harris said doctors have reduced such prescriptions by 17 percent over the past couple of years and are directing patients to other forms of pain management, including physical therapy and cognitive behavioral therapy.